We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Pediatrics

Pediatrics

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Nirsevimab Outperforms Maternal Vaccination in Reducing Severe RSV Outcomes: Insights from Comparative Real-World Evidence
Infectious Diseasesinfectious diseasesmaternal vaccination

Nirsevimab Outperforms Maternal Vaccination in Reducing Severe RSV Outcomes: Insights from Comparative Real-World Evidence

By MedXY|Dec 23, 2025

Recent real-world data from the US and France indicate that while both maternal RSV vaccination and nirsevimab are effective, nirsevimab may offer superior protection against hospitalization and intensive care admission for infants in their

Acute-Onset Axonal Neuropathy Following Infection in Children with Biallelic RCC1 Variants: A Case Series
Neurologycase reportGuillain-Barré syndrome

Acute-Onset Axonal Neuropathy Following Infection in Children with Biallelic RCC1 Variants: A Case Series

By MedXY|Dec 23, 2025

Case series reports acute axonal neuropathy post-infection in children with biallelic RCC1 variants, often misdiagnosed as Guillain-Barré syndrome, showing variable severity and highlighting impaired nucleocytoplasmic transport as pathogeni

Precision Prognostics: Automated EEG Background Analysis and 2-Year Outcomes in Neonatal Hypoxic-Ischemic Encephalopathy
NeurologyHypoxic-Ischemic Encephalopathy

Precision Prognostics: Automated EEG Background Analysis and 2-Year Outcomes in Neonatal Hypoxic-Ischemic Encephalopathy

By MedXY|Dec 21, 2025

This article explores how automated EEG background analysis via the Brain State of the Newborn (BSN) score provides objective, early-life prognostication for neonates with HIE, significantly improving the prediction of 2-year neurodevelopme

Real-World Implementation of RTS,S/AS01E Malaria Vaccine Reduces Severe Malaria by 58%: Evidence from the EPI-MAL-003 Phase 4 Study
Infectious DiseasesPediatricspublic health

Real-World Implementation of RTS,S/AS01E Malaria Vaccine Reduces Severe Malaria by 58%: Evidence from the EPI-MAL-003 Phase 4 Study

By MedXY|Dec 20, 2025

This interim analysis of the phase 4 EPI-MAL-003 study demonstrates that the RTS,S/AS01E malaria vaccine significantly reduces severe malaria, malaria-related hospitalizations, and all-cause hospitalizations in real-world clinical settings

Adolescent Body Dissatisfaction as a Causal Driver of Adult Mental Health: New Insights from a UK Twin Study
newsdepressiontwin study

Adolescent Body Dissatisfaction as a Causal Driver of Adult Mental Health: New Insights from a UK Twin Study

By MedXY|Dec 19, 2025

A longitudinal UK twin study suggests that adolescent body dissatisfaction may causally increase the risk of eating disorders and depression in young adulthood, with significant genetic factors underlying these associations.

Critical CareNeonatologyPediatrics

Optimizing Caffeine Therapy in Preterm Infants: Does Earlier Initiation Improve Respiratory Outcomes?

By MedXY|Dec 19, 2025

This article evaluates the optimal timing and indications for caffeine initiation in preterm neonates, analyzing its impact on chronic lung disease, mortality, and neurodevelopmental outcomes based on the latest 2025 Cochrane evidence.

Probiotics Cut Clostridioides difficile Risk in Antibiotic-Exposed Patients — Small Benefit, Low Certainty
Gastroenterologyantibiotic-associated diarrheaClostridioides difficile

Probiotics Cut Clostridioides difficile Risk in Antibiotic-Exposed Patients — Small Benefit, Low Certainty

By MedXY|Dec 18, 2025

A 2025 Cochrane update finds probiotics may halve the relative risk of C. difficile-associated diarrhea in antibiotic-treated patients (ARR 1.6%, NNT 65) but evidence is low certainty and applicability varies with baseline risk.

High-frequency Oscillatory Ventilation in Near‑Term and Term Infants: Inconclusive Benefit and Possible Increased Mortality — What the 2025 Cochrane Update Tells Clinicians
newscritical caremechanical ventilation

High-frequency Oscillatory Ventilation in Near‑Term and Term Infants: Inconclusive Benefit and Possible Increased Mortality — What the 2025 Cochrane Update Tells Clinicians

By MedXY|Dec 19, 2025

A 2025 Cochrane update (3 RCTs, 368 infants) finds very low- to low-certainty evidence that HFOV neither clearly reduces treatment failure nor pulmonary air leak and may increase mortality versus conventional ventilation in term/near‑term i

Rethinking Oxygen Strategies for Preterm Infant Resuscitation: Evidence from TORPIDO, IPD-MA, and DCC Trials
Critical Careclinical trialoxygen therapy

Rethinking Oxygen Strategies for Preterm Infant Resuscitation: Evidence from TORPIDO, IPD-MA, and DCC Trials

By MedXY|Dec 16, 2025

Recent trials and meta-analyses challenge assumptions about optimal initial oxygen levels for preterm resuscitation.

Immediate and Early Skin-to-Skin Contact After Birth: What the 2025 Cochrane Update Means for Practice
newsBreastfeeding

Immediate and Early Skin-to-Skin Contact After Birth: What the 2025 Cochrane Update Means for Practice

By MedXY|Dec 17, 2025

A clear, evidence-based summary of the 2025 Cochrane review on immediate/early skin-to-skin contact (SSC), its impact on breastfeeding and newborn physiology, gaps in maternal outcomes, and practical recommendations for clinical implementat

Limited Evidence for Behavioural and Service Delivery Interventions in Childhood Epilepsy: Urgent Need for Robust Trials
Neurologybehavioural interventionschildren

Limited Evidence for Behavioural and Service Delivery Interventions in Childhood Epilepsy: Urgent Need for Robust Trials

By MedXY|Dec 16, 2025

Current evidence for behavioural and service delivery interventions in childhood epilepsy is scarce and of low quality, highlighting an urgent need for rigorous, long-term trials.

Methylphenidate for ADHD in Children and Adolescents: Modest Symptom Gains but Uncertain Net Benefit
newsADHDMethylphenidate

Methylphenidate for ADHD in Children and Adolescents: Modest Symptom Gains but Uncertain Net Benefit

By MedXY|Dec 16, 2025

Updated Cochrane analysis (212 RCTs, 16,302 participants) finds methylphenidate may reduce teacher-rated ADHD symptoms and improve general behaviour but increases non‑serious adverse events; overall evidence certainty is very low.

Most Very Preterm Infants Require Hospital Readmission Before Age 2 — Neonatal Morbidities Strongly Increase Days Spent in Hospital
newsneonatal morbidityrehospitalization

Most Very Preterm Infants Require Hospital Readmission Before Age 2 — Neonatal Morbidities Strongly Increase Days Spent in Hospital

By MedXY|Dec 15, 2025

A national cohort study from England and Wales found two-thirds of infants born <32 weeks’ gestation had ≥1 hospital admission before age 2, with lower gestational age and neonatal morbidities (BPD, severe NEC, brain injury) substantiall

Wide International Variation in Survival and Morbidity for Infants Born at 22–23 Weeks: Implications for Care, Counseling, and Research
news

Wide International Variation in Survival and Morbidity for Infants Born at 22–23 Weeks: Implications for Care, Counseling, and Research

By MedXY|Dec 15, 2025

An international cohort of 5,019 infants born at 22–23 weeks shows large between‑network variation in survival and major morbidities, highlighting effects of practice, systems, and policy on outcomes and the need for unified data-driven str

Uncertain Evidence for Youth Suicide Interventions: DBT Shows Promise While Medications and Neurotherapies Remain Largely Unstudied
newspsychosocial interventionssuicide prevention

Uncertain Evidence for Youth Suicide Interventions: DBT Shows Promise While Medications and Neurotherapies Remain Largely Unstudied

By MedXY|Dec 15, 2025

A 2025 systematic review of 65 studies (14,534 youths) finds moderate evidence for dialectical behavior therapy reducing suicidal ideation; other psychosocial interventions have low or insufficient evidence and pharmacologic/neurotherapeuti

Epinephrine Timing and Dosing in Pediatric In‑Hospital Cardiac Arrest: Mixed Signals — improved ROSC but unclear survival benefit
Critical Carepediatric cardiac arrest

Epinephrine Timing and Dosing in Pediatric In‑Hospital Cardiac Arrest: Mixed Signals — improved ROSC but unclear survival benefit

By MedXY|Dec 15, 2025

Recent multicenter studies show earlier and more frequent epinephrine in pediatric in‑hospital cardiac arrest increases ROSC and shortens CPR, but does not consistently improve survival to discharge or favorable neurologic outcome. Evidence

Pediatric In‑Hospital Cardiac Arrest: Why Adult Resuscitation Lessons Don’t Fully Translate — Airway, Epinephrine, and the Limits of Training
Critical Careintubation

Pediatric In‑Hospital Cardiac Arrest: Why Adult Resuscitation Lessons Don’t Fully Translate — Airway, Epinephrine, and the Limits of Training

By MedXY|Dec 15, 2025

Recent multicenter studies show declining intra‑arrest intubation, no clear harm from intubation after time‑dependent matching, unclear benefit of epinephrine before defibrillation, and no survival gain from intensive point‑of‑care CPR trai

Condition-Specific Growth Charts and a New Medical Therapy for Alagille Syndrome: Implications for Growth Assessment and Symptom Control
Gastroenterology

Condition-Specific Growth Charts and a New Medical Therapy for Alagille Syndrome: Implications for Growth Assessment and Symptom Control

By MedXY|Dec 15, 2025

Two recent multicenter studies provide condition-specific growth charts for children with Alagille syndrome and show that ileal bile acid transporter inhibition with odevixibat reduces pruritus and serum bile acids — reshaping growth assess

Reevaluating the Link Between Household Air Pollution from Biomass Cooking and Severe Pneumonia in Infants: A Comprehensive Evidence Synthesis
Clinical Updatescarbon monoxideHousehold air pollution

Reevaluating the Link Between Household Air Pollution from Biomass Cooking and Severe Pneumonia in Infants: A Comprehensive Evidence Synthesis

By MedXY|Dec 14, 2025

Recent high-quality studies challenge the presumed association between household air pollution from biomass cooking and severe infant pneumonia, highlighting inconsistent exposure-response relationships for PM2.5 and CO.

Supplemental Donor Human Milk Did Not Speed Full Enteral Feeding in Moderate–Late Preterm Infants: Results From a Multisite Randomized Trial
newsdonor milkenteral feeding

Supplemental Donor Human Milk Did Not Speed Full Enteral Feeding in Moderate–Late Preterm Infants: Results From a Multisite Randomized Trial

By MedXY|Dec 14, 2025

In a blinded multisite RCT of 201 moderate–late preterm infants, short-term supplementation with pasteurized donor human milk versus term formula did not shorten time to full enteral feeds; donor milk was associated with slower regain of bi

Prev
14 / 25
1…1213141516…25
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities

Browse by specialty

Open language-specific specialty feeds and department pages.

news6629 articlesCardiology1375 articlesClinical Updates1288 articlesOncology1139 articlesDiabetes & Endocrinology842 articlesNeurology820 articlesPublic Health595 articlesGastroenterology572 articles
Hematology-Oncology
487 articles
Pediatrics484 articles
Internal Medicine444 articles